Counter-Strike: SPARTA vs GenOne (BO3) - CCT Europe Series 2 Group Stage

Platform comparison

Active sub-markets

Market context

SPARTA meet GenOne in a best-of-three CCT Europe Series 2 group-stage match, a format where one map swing can decide whether a team stays alive or drops into elimination territory. The current 0% YES price is hard to read as a pure view on map strength; it also reflects how thin pre-match liquidity can be when the market has been late to fund, especially for users still weighing deposit routes and settlement timing. In markets like this, book depth often improves only after funds arrive through lower-friction rails such as card top-ups, SEPA transfers, or USDC, with delayed confirmation on banking rails tending to keep prices pinned until closer to start time.

Comparable CS2 group-stage markets often move less on headline win rates than on practical availability: confirmed line-ups, whether the match is still on schedule, and whether the event operator has posted a live start time. The search results point to SPARTA’s recent losses and GenOne’s slightly stronger recent form, but that kind of form note rarely explains an extreme 0% print on its own; it is more consistent with a market that has not yet attracted enough funded participation to establish a normal two-sided price. Where liquidity is weak, on-ramp friction matters: SEPA users may not settle immediately, while faster funding or existing balances can supply the first real bids and force a reset.

The main catalysts are simple. Traders should watch for official CCT updates, team social posts, and any sign of schedule change before the 17:00 UTC settlement window closes. If the series starts on time and the veto is confirmed, the market is likely to reprice around live participation rather than the current placeholder level. If there is a delay, reschedule, or incomplete match, the resolution rules become more important than the pre-match rating gap, since a cancelled or heavily delayed fixture can push the market to 50-50 regardless of who was favoured beforehand.

Sources: 1 · 2 · 3 · 4 · 5

Methodology

This page reviews Counter-Strike: SPARTA vs GenOne (BO3) - CCT Europe Series 2 Group Stage across five venues. We show live odds for Polymarket-based markets (sourced from the Polygon order book); for other venues we list platform attributes, since the comparable contracts are not exposed via a public API on every venue. Every CTA points at PolyGram — the application we operate, where you trade directly against the Polymarket order book at 0% fees.

Resolution & payout

Polymarket-based markets settle through the UMA Optimistic Oracle on Polygon. A proposer submits the outcome, a two-hour challenge window opens, and unchallenged proposals finalise the resolution. Payouts settle automatically in USDC the moment the result is final — no bookmaker, no delay.

Kalshi-based markets settle in USD via the CFTC-regulated clearinghouse. Betfair Exchange settles in GBP/EUR net of commission. Manifold is play-money and does not pay out real funds.

FAQ

Where can I trade this market with the lowest fees?

On PolyGram, which mirrors the Polymarket order book at 0% fees. Kalshi charges up to 7% per trade; Betfair Exchange takes 2-5% commission on net winnings.

Is this market available outside the US?

PolyGram is available in most jurisdictions where Polymarket isn't directly accessible. Polymarket itself is geo-blocked in the US/UK/EU. Always check local regulations.

How does resolution work?

Through the UMA Optimistic Oracle on Polygon: a proposer submits the outcome, a two-hour challenge window opens, and USDC payouts settle automatically once the result is final.

How fast are USDC deposits?

Polygon credits deposits after 12 confirmations — usually under 30 seconds. Withdrawals follow the same path and land back in your wallet within minutes.

How reliable are the quoted odds?

The YES/NO percentages are the live mid-prices of the Polymarket order book. On deep markets they move every few seconds; on thinner ones you'll see short plateaus.